STE vs ZBH: stock comparison and AI forecast
Steris Plc (STE) and Zimmer Biomet Holdings, Inc. (ZBH) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
STE Steris Plc
- Price
- $252.30 +18.1% · 6M
- Market Cap
- $24.60B
- P/E Ratio
- 31.0x
- Size
- large-cap
- AI Forecast
ZBH Zimmer Biomet Holdings, Inc.
- Price
- $106.85 +28.2% · 6M
- Market Cap
- $20.38B
- P/E Ratio
- 21.9x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- STE is 1.2 times larger than ZBH by market capitalization ($24.60B against $20.38B).
- ZBH trades at 21.9 times trailing earnings, STE at 31.0 times.
- Over the last six months ZBH returned +28.2% and STE +18.1%.
- STE turns 13.2% of its revenue into net income, against 8.9% for ZBH.
- ZBH carries 0.85 times debt per unit of equity, against 0.47 times for STE.
- ZBH yields 0.92% in dividends; STE pays none.
- Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | STE | ZBH |
|---|---|---|
| Market Cap | $24.60B | $20.38B |
| P/E Ratio | 31.00x | 21.94x |
| P/B Ratio | 3.39x | 1.60x |
| Dividend Yield | – | 0.92% |
| EPS | $8.14 | $4.87 |
| Book Value/Share | $74.43 | $66.67 |
| Revenue/Share | – | $44.93 |
| FCF/Share | – | $8.62 |
Profitability & Margins
| Metric | STE | ZBH |
|---|---|---|
| ROE | 11.0% | 6.0% |
| ROA | 7.5% | 3.3% |
| ROIC | 11.8% | 5.8% |
| Gross Margin | 44.4% | 69.7% |
| Operating Margin | 18.4% | 13.6% |
| Net Margin | 13.2% | 8.9% |
| EBT Margin | 17.7% | 10.3% |
| Tax Rate | 25.2% | 13.1% |
Financial Health
| Metric | STE | ZBH |
|---|---|---|
| Current Ratio | 2.05x | 1.46x |
| Quick Ratio | 1.44x | 0.79x |
| D/E Ratio | 0.47x | 0.85x |
| Financial Leverage | 1.48x | 1.85x |
| Interest Coverage | 6.1x | – |
| Working Capital | $1.27B | $1.63B |
Cash Flow
| Metric | STE | ZBH |
|---|---|---|
| Operating Cash Flow | $1.24B | $1.88B |
| Free Cash Flow | – | $1.64B |
| Capital Spending | – | -$241M |
| OCF Growth YoY | -1.8% | 11.8% |
| FCF Growth YoY | – | 10.7% |
| FCF/Sales | – | 19.2% |
| CapEx/Sales | – | 2.8% |
Operational Efficiency
| Metric | STE | ZBH |
|---|---|---|
| Asset Turnover | – | 0.36x |
| Receivables Turnover | – | 4.7x |
| Inventory Turnover | 4.5x | 1.1x |
| Fixed Assets Turnover | – | 3.7x |
| Days Sales Outstanding | – | 77 days |
| Days Inventory | 80 days | 332 days |
| Payables Period | 37 days | 50 days |
| Cash Conversion Cycle | – | 360 days |
Income Statement
| Metric | STE | ZBH |
|---|---|---|
| Total Revenue | – | $8.57B |
| Operating Income | $1.12B | $1.16B |
| Net Income | $800M | $767M |
| R&D Expense | $118M | $433M |
| SG&A Expense | $1.44B | $3.48B |
| Cost of Goods Sold | $3.34B | $2.60B |
Dividend & Shareholder Information
| Metric | STE | ZBH |
|---|---|---|
| Dividends Per Share | – | $0.98 |
| Payout Ratio | – | 20.1% |
| Shares Outstanding | 98M | 191M |
| Net Income Growth | 16.1% | -4.7% |
| EPS Growth | 24.7% | 23.3% |
STE vs ZBH: stock comparison and AI forecast
Which is bigger, STE or ZBH?
STE is 1.2 times larger than ZBH by market capitalization ($24.60B against $20.38B).
Which is cheaper on earnings, STE or ZBH?
ZBH trades at 21.9 times trailing earnings, STE at 31.0 times.
Which stock performed better over the last six months, STE or ZBH?
Over the last six months ZBH returned +28.2% and STE +18.1%.
Which one does Intratio's AI model rank higher, STE or ZBH?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.